- Home
- XRTX vs EVOK Comparison
XRTX vs EVOK Comparison
Compare XRTX & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XRTX
- EVOK
- Stock Information
- Founded
- XRTX 2011
- EVOK 2007
- Country
- XRTX Canada
- EVOK United States
- Employees
- XRTX N/A
- EVOK N/A
- Industry
- XRTX Pharmaceuticals and Biotechnology
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- XRTX Health Care
- EVOK Health Care
- Exchange
- XRTX Nasdaq
- EVOK Nasdaq
- Market Cap
- XRTX 5.0M
- EVOK 4.2M
- IPO Year
- XRTX N/A
- EVOK 2013
- Fundamental
- Price
- XRTX $1.82
- EVOK $5.34
- Analyst Decision
- XRTX Strong Buy
- EVOK
- Analyst Count
- XRTX 1
- EVOK 0
- Target Price
- XRTX $14.00
- EVOK N/A
- AVG Volume (30 Days)
- XRTX 125.9K
- EVOK 40.2K
- Earning Date
- XRTX 11-14-2024
- EVOK 11-07-2024
- Dividend Yield
- XRTX N/A
- EVOK N/A
- EPS Growth
- XRTX N/A
- EVOK N/A
- EPS
- XRTX N/A
- EVOK N/A
- Revenue
- XRTX N/A
- EVOK $7,525,709.00
- Revenue This Year
- XRTX N/A
- EVOK $124.10
- Revenue Next Year
- XRTX N/A
- EVOK $75.70
- P/E Ratio
- XRTX N/A
- EVOK N/A
- Revenue Growth
- XRTX N/A
- EVOK 110.79
- 52 Week Low
- XRTX $1.09
- EVOK $3.54
- 52 Week High
- XRTX $67.72
- EVOK $17.88
- Technical
- Relative Strength Index (RSI)
- XRTX 53.06
- EVOK 57.79
- Support Level
- XRTX $1.52
- EVOK $4.81
- Resistance Level
- XRTX $2.51
- EVOK $5.43
- Average True Range (ATR)
- XRTX 0.28
- EVOK 0.47
- MACD
- XRTX 0.04
- EVOK 0.01
- Stochastic Oscillator
- XRTX 31.00
- EVOK 55.46
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.